Research led by the New York State Psychiatric Institute, New York, has looked into non-medical lysergic acid diethylamide (LSD) use by people with major depression status and their ...

A single oral administration of an LSD-based medicine provided rapid and durable improvement in moderate to severe generalized anxiety disorder (GAD) in a phase 2B study.

A study from the New York State Psychiatric Institute reveals a 450% increase in non-medical LSD use among US adults with major depression, emphasizing the need for informed, safe use.

In 1970, the U.S. Congress passed the Controlled Substances Act, which classified LSD along with several other hallucinogens as having a high potential for abuse and no accepted medical use. In ...

Scientists have long known that psychedelics like LSD can help the brain grow new connections. These drugs promote something called neuroplasticity, which helps the brain heal from mental illness.

Mind Medicine Inc. (MindMed) shares rose 10% in premarket trades on Thursday after the company said patient dosing in its Phase 2b trial is ongoing and offers a "highly attractive commercial ...